scRNA-seq characterizing the heterogeneity of fibroblasts in breast cancer reveals a novel subtype SFRP4+ CAF that inhibits migration and predicts prognosisLvwen Ning, Ni Xie, Chuntao Quan et al.|Frontiers in Oncology|2024Cited by 17